“Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025026, Feb. 2025, doi: 10.4084/MJHID.2025.026.